Patents by Inventor Deepa Ashok Khambe

Deepa Ashok Khambe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10267797
    Abstract: Methods for detecting and quantifying toxins present in the oral cavity. The methods may include providing a biological sample, providing reporter cells expressing one or more Toll like receptors, exposing the cells to the biological sample, measuring the EC50 value of the lipopolysaccharide on activation of a Toll like receptor, quantification of the lipopolysaccharide in the biological sample.
    Type: Grant
    Filed: March 29, 2018
    Date of Patent: April 23, 2019
    Assignee: The Procter & Gamble Company
    Inventors: John Christian Haught, Sancai Xie, Benjamin Thomas Circello, Cheryl Sue Tansky, Malgorzata Klukowska, Thomas Glenn Huggins, Deepa Ashok Khambe, Donald James White
  • Publication number: 20180231546
    Abstract: Methods for detecting and quantifying toxins present in the oral cavity. The methods may include providing a biological sample, providing reporter cells expressing one or more Toll like receptors, exposing the cells to the biological sample, measuring the EC50 value of the lipopolysaccharide on activation of a Toll like receptor, quantification of the lipopolysaccharide in the biological sample.
    Type: Application
    Filed: March 29, 2018
    Publication date: August 16, 2018
    Inventors: John Christian Haught, Sancai Xie, Benjamin Thomas Circello, Cheryl Sue Tansky, Malgorzata Klukowska, Thomas Glenn Huggins, Deepa Ashok Khambe, Donald James White
  • Patent number: 9970934
    Abstract: Methods for detecting and quantifying toxins present in the oral cavity. The methods may include providing a biological sample, providing reporter cells expressing one or more Toll like receptors, exposing the cells to the biological sample, measuring the EC50 value of the lipopolysaccharide on activation of a Toll like receptor, quantification of the lipopolysaccharide in the biological sample.
    Type: Grant
    Filed: May 6, 2016
    Date of Patent: May 15, 2018
    Assignee: The Procter & Gamble Company
    Inventors: John Christian Haught, Sancai Xie, Benjamin Thomas Circello, Cheryl Sue Tansky, Malgorzata Klukowska, Thomas Glenn Huggins, Deepa Ashok Khambe, Donald James White
  • Patent number: 9964472
    Abstract: One or more methods for sampling gingival metabolites and biomarkers.
    Type: Grant
    Filed: June 29, 2016
    Date of Patent: May 8, 2018
    Assignee: The Procter & Gamble Company
    Inventors: Sancai Xie, John Christian Haught, Cheryl Sue Tansky, Thomas Glenn Huggins, Jr., Donald James White, Jr., Lijuan Li, Malgorzata Klukowska, Angela Marie Fieno, Deepa Ashok Khambe
  • Publication number: 20180003598
    Abstract: One or more methods for sampling gingival metabolites and biomarkers.
    Type: Application
    Filed: June 29, 2016
    Publication date: January 4, 2018
    Inventors: Sancai XIE, John Christian HAUGHT, Cheryl Sue TANSKY, Thomas Glenn HUGGINS, JR., Donald James WHITE, JR., Lijuan LI, Malgorzata KLUKOWSKA, Angela Marie FIENO, Deepa Ashok KHAMBE
  • Publication number: 20160327557
    Abstract: Methods for detecting and quantifying toxins present in the oral cavity. The methods may include providing a biological sample, providing reporter cells expressing one or more Toll like receptors, exposing the cells to the biological sample, measuring the EC50 value of the lipopolysaccharide on activation of a Toll like receptor, quantification of the lipopolysaccharide in the biological sample.
    Type: Application
    Filed: May 6, 2016
    Publication date: November 10, 2016
    Inventors: John Christian HAUGHT, Sancai XIE, Benjamin Thomas CIRCELLO, Cheryl Sue TANSKY, Malgorzata KLUKOWSKA, Thomas Glenn HUGGINS, Deepa Ashok KHAMBE, Donald James WHITE
  • Patent number: 5843987
    Abstract: The present invention relates to the use of ellagic acid for the treatment of gastrointestinal disorders by stimulating the motility of the GI tract. In particular the present invention relates to a method of treatment of constipation, heartburn, non ulcer dyspepsia, GERD, and/or esophagitis, with a pharmaceutical composition comprising a safe and effective amount of ellagic acid or pharmaceutically acceptable salts or esters thereof. Preferably the ellagic acid is administered perorally.
    Type: Grant
    Filed: October 31, 1997
    Date of Patent: December 1, 1998
    Assignee: The Procter & Gamble Company
    Inventors: Tuticorin Govindachari Rajagopalan, Deepa Ashok Khambe